↓ Skip to main content

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients

Overview of attention for article published in Orphanet Journal of Rare Diseases, May 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients
Published in
Orphanet Journal of Rare Diseases, May 2017
DOI 10.1186/s13023-017-0655-8
Pubmed ID
Authors

Florian Lasch, Kristina Weber, Mwe Mwe Chao, Armin Koch

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 19%
Researcher 5 16%
Student > Bachelor 4 13%
Other 3 9%
Student > Master 2 6%
Other 3 9%
Unknown 9 28%
Readers by discipline Count As %
Medicine and Dentistry 10 31%
Mathematics 5 16%
Biochemistry, Genetics and Molecular Biology 3 9%
Sports and Recreations 1 3%
Decision Sciences 1 3%
Other 1 3%
Unknown 11 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2019.
All research outputs
#5,842,942
of 23,140,503 outputs
Outputs from Orphanet Journal of Rare Diseases
#741
of 2,650 outputs
Outputs of similar age
#91,923
of 313,997 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#22
of 54 outputs
Altmetric has tracked 23,140,503 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,650 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,997 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.